Technical Analysis for CVKD - Cadrenal Therapeutics, Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | N/A | N/A | N/A |
Date | Alert Name | Type | % Chg |
---|---|---|---|
New 52 Week Closing Low | Bearish | 0.00% | |
Hot IPO Pullback | Bullish Swing Setup | 0.00% | |
New 52 Week Low | Weakness | 0.00% | |
Gapped Up | Strength | 0.00% | |
Down 3 Days in a Row | Weakness | 0.00% | |
New 52 Week Closing Low | Bearish | -2.07% | |
Hot IPO Pullback | Bullish Swing Setup | -2.07% | |
New 52 Week Low | Weakness | -2.07% | |
Gapped Down | Weakness | -2.07% | |
New 52 Week Closing Low | Bearish | -11.25% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
Alert | Time |
---|---|
Hot IPO Pullback Entry | about 9 hours ago |
Rose Above Previous Day's High | about 9 hours ago |
New 52 Week High | about 9 hours ago |
Outside Day | about 9 hours ago |
Up 5% | about 9 hours ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: ???
Cadrenal Therapeutics, Inc. operates as a clinical development biopharmaceutical company. The company focuses on developing Tecarfarin, a novel therapy with orphan drug indication for the prevention of systemic thromboembolism of cardiac origin in patients with end-stage renal disease and atrial fibrillation. The company was incorporated in 2022 and is headquartered in Ponte Vedra, Florida.
Keywords: Health Sciences Hematology End Stage Renal Disease Cardiac Arrhythmia Atrial Fibrillation Venous Thrombosis
Classification
Keywords: Health Sciences Hematology End Stage Renal Disease Cardiac Arrhythmia Atrial Fibrillation Venous Thrombosis
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 6.1 |
52 Week Low | 2.8 |
Average Volume | 567,075 |
200-Day Moving Average | 0.00 |
50-Day Moving Average | 0.00 |
20-Day Moving Average | 0.00 |
10-Day Moving Average | 0.00 |
Average True Range | 0.00 |
RSI | 0.00 |
ADX | 0.0 |
+DI | 0.00 |
-DI | 0.00 |
Chandelier Exit (Long, 3 ATRs) | N/A |
Chandelier Exit (Short, 3 ATRs) | N/A |
Upper Bollinger Bands | 0.00 |
Lower Bollinger Band | 0.00 |
Percent B (%b) | 0.0 |
BandWidth | 0.00 |
MACD Line | 0.00 |
MACD Signal Line | 0.00 |
MACD Histogram | 0.0 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 3.26 | ||||
Resistance 3 (R3) | 3.29 | 3.19 | 3.19 | ||
Resistance 2 (R2) | 3.19 | 3.08 | 3.17 | 3.17 | |
Resistance 1 (R1) | 3.01 | 3.01 | 2.96 | 2.98 | 3.14 |
Pivot Point | 2.91 | 2.91 | 2.88 | 2.89 | 2.91 |
Support 1 (S1) | 2.73 | 2.80 | 2.68 | 2.70 | 2.54 |
Support 2 (S2) | 2.63 | 2.73 | 2.61 | 2.51 | |
Support 3 (S3) | 2.45 | 2.63 | 2.49 | ||
Support 4 (S4) | 2.42 |